Marijuana Policy Project | June 15, 2017 WASHINGTON, DC

New Post Public Reply Private Reply Replies (0) Message Board
CyberC
1,707
Marijuana Policy Project | June 15, 2017

WASHINGTON, DC — United States Senators Rand Paul (R-KY), Corey Booker (D-NJ), and Kirsten Gillibrand (D-NY) reintroduced a bill Thursday that would end the federal prohibition of medical marijuana. Sens. Mike Lee (R-UT) and Lisa Murkowski (R-AK) also signed on to the legislation as original co-sponsors.

The Compassionate Access, Research Expansion, and Respect States (or CARERS) Act of 2017 would allow individuals and entities to possess, produce, and distribute medical marijuana if they are in compliance with state medical marijuana laws. It would also open up avenues to medical marijuana research and allow physicians employed by the Department of Veterans Affairs to recommend medical marijuana to veterans in states where it is legal. The bill also proposes excluding cannabidiol, a non-psychoactive cannabinoid found in marijuana, from the federal government’s definition of “marijuana.”

This is the second time the CARERS Act has been introduced. It was first introduced on March 10, 2015, during the 114th Congress.

Twenty-nine states, the District of Columbia, and the U.S. territories of Guam and Puerto Rico have enacted effective medical marijuana laws. An additional 19 states have adopted laws that recognize the medical value of marijuana but are unworkable or exceptionally limited.

According to an April poll conducted by Quinnipiac University, 94 percent of U.S. voters support allowing adults to legally use marijuana for medical purposes, including 96 percent of Democrats, 90 percent of Republicans, and 95 percent of independents.

“The reintroduction of the CARERS Act is the first of many steps we hope this Congress will take to end the federal prohibition of medical marijuana,” Don Murphy, director of conservative outreach for the Marijuana Policy Project, said in a statement. “The addition of Sens. Lee and Murkowski as original co-sponsors should inspire other Republicans to seriously consider this legislation and the absurd federal overreach that it seeks to correct. Marijuana is effective in the treatment of several debilitating conditions. The federal government should not be meddling in state laws that allow it or obstructing research into its many medical benefits.

“Polls show overwhelmingly strong support for medical marijuana, and it spans the political spectrum. There is no better example of an issue that garners the level of bipartisan support necessary to pass meaningful legislation. Twenty-nine states and our nation’s capital have enacted effective medical marijuana programs, and an additional 19 states have adopted laws that recognize marijuana’s medical value. There is no rational reason to continue prohibiting seriously ill patients from using this medicine or punishing those who provide it to them,” added Murphy.

Signal Bay Inc. (SGBY) Stock Research Links

SGBY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

New Era Celebrates Valkyries' Groundbreaking WNBA Win

Updated Category News Views 7

A Surprising Win for a Rising Team In the world of sports, sometimes the odds are defied, and stories of triumph unfold that capture the imagination. The Golden State Valkyries did exactly that by snagging their first WNBA Championship title just a year after entering the league. It's a narrative right out of a Hollywood script—only this time, it's inked in real...

Continue Reading
Shenzhen's Theme Song Unveils APEC 2026 Vision

Updated Category News Views 171

A Harmonious Prelude to APEC China 2026 Ever experienced an anthem that captures a city's pulse? That's what Shenzhen's latest creation aims for as it gears up for APEC China 2026. The Publicity Department of the CPC Shenzhen Municipal Committee, alongside Shenzhen Media Group, has crafted something more than just a tune. This is 'Meet You Where Wonders Bloom', a melody...

Continue Reading
Mastering Progressive Overload: Break Workout Plateaus

Updated Category News Views 120

Getting off the Fitness Merry-Go-Round You've been hitting the gym, feeling great, and suddenly—bam! You've hit a wall so hard you might as well be a bug on a windshield. That's where our buddy Joshua Bankes comes in, explaining the magic of progressive overload for fitness buffs. Understanding Plateau Phenomena Remember, results aren't linear. As you start a new...

Continue Reading
TESSAN and Jamie Leibert's Daring Alpine Documentary Launch

Updated Category News Views 113

Steps Beyond the Obvious Adventure Launching headlong into the unknown—literally and figuratively—is what the documentary Jump Into The Unknown captures. TESSAN and Jamie Leibert have peeled back the curtain on adventure, showing us that it’s not just about the destination, but every twist, turn, and recalibrated step in between. The Backstory Behind Every Jump...

Continue Reading
Smart Salary Moves for S Corp Owners: Riggs Unpacks Insights

Updated Category News Views 192

Decoding the S Corp Salary Dance How much salary should the savvy owners of S corporations draw? It ain't a simple task or one-size-fits-all deal, folks. David Riggs spills the beans on HelloNation, sharing insights on this complex tango between drawing wages and raking in shareholder distributions. In the end, it’s about playing by the IRS rules—or risking a penalty...

Continue Reading
OlloBot's Emotional AI Robots Connect Beyond Tasks

Updated Category News Views 344

OlloBot Eyes Emotional Bonds, Not Just Robotics Power Is it just me, or is OlloBot onto something deep with their emotional AI companions? They've set a course that might just redefine how we perceive home robotics. At IFA Berlin 2026, they didn't just strut their technical stuff. Nope, they took it beyond gears and gadgets, turning heads with a robot that does more than...

Continue Reading
Dutch Bros Pours Holiday Cheer with New Festive Menu

Updated Category News Views 69

New Festive Offerings from Dutch Bros Kicking off the holiday season with a splash of vibrant flavors, Dutch Bros is shaking up the menu with some fresh, festive entries. Two new drink concoctions hit the stage alongside a themed delectable treat, and for those traditionalists, perennial favorites make a triumphant return. Dutch Bros Expands Its Vibrant Lineup It's not...

Continue Reading
Fluence Energy Faces Class Action: Investors Beware

Updated Category News Views 343

Storm Clouds Over Fluence Energy I'll tell you, I ain't surprised when companies face the music for dressing up their books. Fluence Energy, Inc. (NASDAQ: FLNC)—those wallopers are now caught in a legal maelstrom with a securities fraud class action lawsuit hanging over their heads. It's hard to feel sorry for 'em when the writing's on the wall. Allegations and...

Continue Reading
ModelBest & OpenBMB Unveil Open-Source OCR Models

Updated Category News Views 244

A New Frontier in Document Parsing Just when you thought document parsing couldn't get any more advanced, ModelBest and OpenBMB come along with a game-changing release: the MiniCPM-OCR series. This duo of dynamite models, MiniCPM-OCR 1.0 and Jev, is all about taking the efficiency and performance expectations for open-source OCR models up a couple of notches. If you're an...

Continue Reading
CPC's Rigorous Self-Governance Balances Power Effectively

Updated Category News Views 23

What's the Deal With Those Ancient Quotes? There's nothing like a quote from the Warring States Period to set the stage for good ol' fashioned governance chatter. Lu Buwei's words about rulers and compass points is historic, sure, but it speaks to the core need for standards in today's China. This isn't just some fortune cookie wisdom; it's a clarion call for order and...

Continue Reading

Top 5 Most Recently Viewed Articles

Maritime Partners Expands with Acquisition of Centerline Logistics

Updated Category News Views 352

Maritime Partners Makes Strategic Move to Acquire Centerline Logistics Maritime Partners, LLC, known for its expertise in maritime financing solutions focusing primarily on Jones Act vessels, recently announced a significant acquisition. The company intends to acquire the esteemed marine transportation provider, Centerline Logistics. This deal comes at a time when...

Continue Reading
Ciena Corp Surprises Investors with Strong Earnings Growth

Updated Category News Views 149

U.S. Stock Market Overview On a day marked by volatility, U.S. stocks experienced a downturn with the Dow Jones Industrial Average dropping over 1%. The index fell by 1.07% to 41,462.06, while the S&P 500 lost 0.66%, closing at 5,577.74. Concurrently, the NASDAQ saw a minor decline of 0.19%, ending at 17,434.41. Market Sector Movements The market dynamics presented a...

Continue Reading
Rare Diseases Market to Reach USD 547.5 Billion by 2030

Updated Category News Views 96

Overview of the Rare Diseases Market and Future Growth The market for rare diseases is witnessing impressive growth. Recent forecasts suggest that its value will rise from USD 161.4 billion to around USD 547.5 billion by the end of the decade. This surge represents a substantial compound annual growth rate (CAGR) of 13.1%, highlighting a strong demand for advancements in...

Continue Reading
VEON's Strategic Shift to Dubai: A New Era for the Company

Updated Category News Views 145

VEON Transitions Headquarters to Dubai: A Strategic Decision VEON Ltd. (Nasdaq: VEON, Euronext Amsterdam: VEON), a leading global digital operator, has recently made the significant decision to relocate its headquarters from Amsterdam to the bustling Dubai International Financial Centre (DIFC). This strategic move comes as part of VEON's continual evolution and its...

Continue Reading
Capricor Therapeutics Faces Class Action Lawsuit Over Issues

Updated Category News Views 245

Overview of the Class Action Lawsuit Against Capricor Therapeutics Capricor Therapeutics, Inc., known by its ticker symbol CAPR, is currently facing a shareholder class action lawsuit. This legal action centers around allegations that the company made materially false and misleading statements regarding critical safety and efficacy data from its Phase 2 HOPE-2 trial study...

Continue Reading